ZIM Laboratories gets nod to invest Rs 2 crore in ZIMTAS

14 May 2024 Evaluate

ZIM Laboratories has received approval for investment of upto Rs 2 crore in equity shares of ZIMTAS, subsidiary of the company. The Investment is with an objective of Business Development in Australian and New Zealand markets. With the proposed investment, the company’s shareholding in ZIMTAS will change from 99% to 99.97%. The Board of Directors of the company in their meeting held on May 13, 2024 has inter-alia considered and approved the same. 

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develops generic pharmaceutical products.


Zim Laboratories Share Price

103.35 -0.95 (-0.91%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.